Lenalidomide

Form: Oral Capsules

Strength: 2.5 mg, 5 mg, 10 mg, 15 mg, 25 mg

Reference Brands: Revlimid® (EU & US)

Category: Oncology Cancer Care

Lenalidomide is an immunomodulatory drug (IMiD) used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL). Available under the brand Revlimid® by Bristol Myers Squibb, it is offered in oral capsule form in strengths ranging from 2.5 mg to 25 mg. Lenalidomide works by enhancing the immune system and inhibiting tumor cell growth. Widely sourced by B2B pharmaceutical wholesalers in the US and EU, it ensures reliable supply of high-quality, GMP-compliant medications for oncology centers, providing competitive pricing for cancer treatments.